PHASE 1
Clinical trials for PHASE 1 explained in plain language.
Never miss a new study
Get alerted when new PHASE 1 trials appear
Sign up with your email to follow new studies for PHASE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat kidney cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for people with advanced clear cell kidney cancer that has not responded to standard therapies. The treatment uses donor immune cells (NK cells) that are modified to better recognize and attack cancer cells while resisting the tumor's …
Matched conditions: PHASE 1
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Engineered immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment made from a person's own immune cells (NK cells) that are engineered to recognize and attack melanoma cells carrying a protein called PRAME. The study enrolls adults with advanced melanoma that has not responded to standard immunothera…
Matched conditions: PHASE 1
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Healthy volunteers needed to test how food and acid reducers affect new drug absorption
Knowledge-focused Recruiting nowThis early-stage study in 16 healthy adults aims to compare how well a new tablet form of the experimental drug PF-07799933 is absorbed versus the current form. It also checks if a high-fat meal or an acid-reducing drug changes absorption. Participants take a single dose of the d…
Matched conditions: PHASE 1
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC